Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) VP Douglas J. Batdorff sold 3,470 shares of the business’s stock in a transaction on Monday, December 30th. The shares were sold at an average price of $65.50, for a total transaction of $227,285.00. Following the completion of the transaction, the vice president now directly owns 5,000 shares of the company’s stock, valued at $327,500. This trade represents a 40.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Kewaunee Scientific Price Performance
Shares of KEQU opened at $62.00 on Friday. The stock has a 50 day simple moving average of $45.63 and a 200 day simple moving average of $44.05. Kewaunee Scientific Co. has a 52-week low of $27.00 and a 52-week high of $67.20. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.00 and a current ratio of 2.53. The firm has a market capitalization of $178.06 million, a PE ratio of 9.83 and a beta of 0.80.
Analyst Ratings Changes
Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a report on Wednesday, December 18th.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Dimensional Fund Advisors LP raised its holdings in shares of Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock worth $8,378,000 after acquiring an additional 6,132 shares during the period. Renaissance Technologies LLC increased its holdings in Kewaunee Scientific by 13.4% during the 2nd quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after purchasing an additional 10,580 shares in the last quarter. De Lisle Partners LLP raised its stake in shares of Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Kewaunee Scientific by 8.9% in the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares in the last quarter. Finally, Ritholtz Wealth Management boosted its position in shares of Kewaunee Scientific by 24.6% during the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after buying an additional 2,156 shares during the period. Institutional investors and hedge funds own 32.69% of the company’s stock.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
- Five stocks we like better than Kewaunee Scientific
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Insiders Are Selling, But These 3 Stocks Are Must-Buys
- Trading Stocks: RSI and Why it’s Useful
- Rivian Defies Doubters: Delivery Triumph Fuels Stock Surge
- Stock Sentiment Analysis: How it Works
- Hindenburg Short Report Slams Carvana Over Alleged ‘Grift’
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.